| 【英語論文】 |
| |
原著論文 |
| |
|
1. Yasui K, Matsuyama N, Okamura-Shiki I, Ikeda T, Ishii K, Furuta RA and Hirayama F: Clinical utility of a passive immune basophil activation test for the analysis of allergic transfusion reactions. Transfusion, 2017; 57: 2084-2095. |
| |
|
2. Okamura-Shiki I, Matsuyama N, Yasui K, Hirayama F and Ikeda T: Clinical utility of the basophil activation test for analysis of allergic transfusion reactions: a pilot study. Vox Sang. 2017; 112: 114-121. |
| |
|
3. Aoyama T, Imataki O, Mori K, Yoshitsugu K, Fukaya M, Okamura I, Enami T, Tatara R and Ikeda T: Nutritional risk in allogeneic stem cell transplantation: rationale for a tailored nutritional pathway. Annals of Hematology. 2017; 96: 617-625. |
| |
|
4. Murata M, Ikegame K, Morishita Y, Ogawa H, Kaida K, Nakamae H, Ikeda T, Nishida T, Inoue M, Eto T, Kubo K, Sakura T, Mori T, Uchida N, Ashida T, Matsuhashi Y, Miyazaki Y, Ichinohe T, Atsuta Y and Teshima T: Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT. Bone Marrow Transplantation. 2017; 52: 252-257. |
| |
|
|
| 【和文論文】 |
| |
解説その他 |
| |
|
1. Ando K, Chou T, Suzuki K, Shinagawa A, Uchida T, Taniwaki M, Hirata H, Ishizawa K, Matsue K, Okamoto S, Otsuka M, Matsumoto M, Iida S, Matsumura I, Ikeda T, Takezako N, Ogaki Y, Midorikawa S, Houck V, Ervin-Haynes A, Terui Y: [Lenalidomide and low-dose dexamethasone therapy for Japanese patients with newly diagnosed multiple myeloma: updated results of the MM-025 study]. Rinsho Ketsueki. 2017; 58: 2219-2226. |
